Literature DB >> 10616865

Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.

G G Brown1, A A Rahill, J M Gorell, C McDonald, S J Brown, M Sillanpaa, C Shults.   

Abstract

Two studies examined the validity of the Dementia Rating Scale (DRS) as a measure of cognitive functioning among patients with Parkinson's disease (PD). The DRS accounted for more variation in the level of cognitive functioning of PD patients than either the Mini-Mental Status Examination or a battery of tests selected to assess specific cognitive deficits associated with PD. Further, DRS subtests displayed strong convergent and discriminant validity with a comprehensive Criterion Neuropsychology Battery. The DRS subtests appear to be valid measures of attention, perseveration, conceptualization, and memory among PD patients. However, the DRS-Construction subtest should be supplemented with additional visuoconstructional items to provide a thorough screen of cognitive functioning in PD. Although about three-quarters of nondemented PD patients did not appear to have any specific cognitive deficits on the DRS, the remaining patients were impaired on the Construction or Initiation/Perseveration subtests of the DRS. In summary, the DRS is a valid mental status screening test of cognitive functioning for individuals with PD.

Entities:  

Mesh:

Year:  1999        PMID: 10616865     DOI: 10.1177/089198879901200403

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  24 in total

1.  Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale.

Authors:  Gregory M Pontone; Justin Palanci; James R Williams; Susan Spear Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2012-05-24       Impact factor: 3.485

2.  Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study.

Authors:  Cindy M de Frias; Roger A Dixon; Richard Camicioli
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

3.  Computational Models Inform Clinical Science and Assessment: An Application to Category Learning in Striatal-Damaged Patients.

Authors:  W Todd Maddox; J Vincent Filoteo; Dagmar Zeithamova
Journal:  J Math Psychol       Date:  2010-02-01       Impact factor: 2.223

4.  CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Authors:  A Siderowf; S X Xie; H Hurtig; D Weintraub; J Duda; A Chen-Plotkin; L M Shaw; V Van Deerlin; J Q Trojanowski; C Clark
Journal:  Neurology       Date:  2010-08-18       Impact factor: 9.910

5.  The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.

Authors:  Michèle Kiesmann; Jean-Baptiste Chanson; Julien Godet; Thomas Vogel; Laetitia Schweiger; Saïd Chayer; Georges Kaltenbach
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

Review 6.  Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.

Authors:  Jeroen Hoogland; Lennard L van Wanrooij; Judith A Boel; Jennifer G Goldman; Glenn T Stebbins; John C Dalrymple-Alford; Connie Marras; Charles H Adler; Carme Junque; Kenn F Pedersen; Brit Mollenhauer; Cyrus P Zabetian; Paul J Eslinger; Simon J G Lewis; Ruey-Meei Wu; Martin Klein; Maria C Rodriguez-Oroz; Davide M Cammisuli; Paolo Barone; Roberta Biundo; Rob M A de Bie; Ben A Schmand; Alexander I Tröster; David J Burn; Irene Litvan; J Vincent Filoteo; Gert J Geurtsen; Daniel Weintraub
Journal:  Mov Disord       Date:  2018-09-14       Impact factor: 10.338

7.  Global cognitive scores do not predict outcome after subthalamic nucleus deep brain stimulation.

Authors:  Darlene Floden; Robyn M Busch; Scott E Cooper; Cynthia S Kubu; Andre G Machado
Journal:  Mov Disord       Date:  2015-07-14       Impact factor: 10.338

8.  Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.

Authors:  D Aarsland; I Litvan; D Salmon; D Galasko; T Wentzel-Larsen; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

9.  Predictors of health status in nondepressed and nondemented individuals with Parkinson's disease.

Authors:  Dawn M Schiehser; S Duke Han; Stephanie Lessig; David D Song; Vanessa Zizak; J Vincent Filoteo
Journal:  Arch Clin Neuropsychol       Date:  2009-09-18       Impact factor: 2.813

10.  Cognitive complaints in Parkinson's disease: its relationship with objective cognitive decline.

Authors:  Kathy Dujardin; Alain Duhamel; Marie Delliaux; Catherine Thomas-Antérion; Alain Destée; Luc Defebvre
Journal:  J Neurol       Date:  2009-08-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.